Published in Transplant Proc on December 01, 1994
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg (1991) 2.55
A designed metal-binding protein with a novel fold. Nature (1993) 2.48
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology (2000) 2.15
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev (2010) 2.09
Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg (1999) 2.00
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut (2002) 1.98
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant (2014) 1.77
Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett (1998) 1.55
Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg (1995) 1.54
Adequacy of margins of resection in gastrectomy for cancer. Ann Surg (1982) 1.52
Double versus single stapling technique in rectal anastomosis. Int J Colorectal Dis (1992) 1.47
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ (1994) 1.47
Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. Br J Surg (1993) 1.46
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Comparing reconstruction with Roux-en-Y to a pouch following total gastrectomy. J Am Coll Surg (1996) 1.44
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology (1991) 1.43
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer (1974) 1.43
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 1.40
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol (1992) 1.40
A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem (1996) 1.40
Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. Transplant Proc (1988) 1.37
Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer (2001) 1.36
FK 506 as a growth control factor. Transplant Proc (1990) 1.36
Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology (2000) 1.32
Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol (1996) 1.32
Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg (1997) 1.32
A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol (1996) 1.29
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet (1986) 1.27
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology (1989) 1.21
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology (1997) 1.20
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg (1987) 1.19
Childbearing after liver transplantation. Transplantation (1990) 1.19
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg (1998) 1.17
Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet (1989) 1.17
Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis (2010) 1.16
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg (1986) 1.15
Surgical treatment of hepatic metastases from colorectal cancer. Ann Surg (1986) 1.14
Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts. Transpl Int (1988) 1.14
A tyrosine-based sorting signal in the beta2 integrin cytoplasmic domain mediates its recycling to the plasma membrane and is required for ligand-supported migration. EMBO J (1999) 1.14
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab (2001) 1.13
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol (1988) 1.12
Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: an in vitro study. Gastroenterology (1980) 1.12
Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology (1994) 1.12
Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody. Protein Sci (1996) 1.11
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci (2005) 1.11
Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation. Dig Dis Sci (1989) 1.10
Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Q J Nucl Med Mol Imaging (2011) 1.10
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer (2006) 1.10
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.08
Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach. Surg Endosc (2001) 1.08
Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet (1987) 1.08
Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endosc (2003) 1.07
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int (2003) 1.07
Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur J Surg Oncol (2010) 1.07
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. Biochemistry (1998) 1.07
Endogenous morphine. Trends Neurosci (2000) 1.07
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol (1998) 1.05
5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer (1998) 1.04
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients. Br J Cancer (2001) 1.03
Cavitron Ultrasonic Surgical Aspirator (CUSA) in liver resection. Int Surg (1992) 1.03
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology (1991) 1.02
A clinicopathologic study of primary hepatic carcinoid tumors. Cancer (1990) 1.02
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol (1998) 1.02
Pharmacokinetic profile of fosfomycin trometamol (Monuril). Eur Urol (1987) 1.02
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut (2006) 1.01
Dup(3)(p2----pter) in two families, including one infant with cyclopia. Am J Med Genet (1985) 1.01
Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol (2000) 1.01
Substrate specificity of the hepatitis C virus serine protease NS3. J Biol Chem (1997) 1.01
The role of pH, temperature, salt type, and salt concentration on the stability of the crystalline, helical, and randomly coiled forms of collagen. J Biol Chem (1967) 1.01
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres. Q J Nucl Med Mol Imaging (2012) 1.01
The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology (1989) 1.01
CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology (2006) 1.01
Further steps of hepatic stimulatory substance purification. Dig Dis Sci (1991) 1.01
Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes (1992) 1.01
Comparison of nutritional status after total or subtotal gastrectomy. Nutrition (1992) 1.00
Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library. J Biol Chem (1999) 1.00
Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci (1988) 1.00
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver. Dig Dis Sci (1991) 1.00
Chordoma: natural history and treatment results in 33 cases. J Surg Oncol (1988) 0.99
CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes. Eur J Immunol (1996) 0.99
Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. J Mol Biol (1999) 0.99
Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol (1990) 0.99